Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study
2008

Factors Affecting Prothrombin Time Normalization After Stopping Warfarin

Sample size: 202 publication Evidence: moderate

Author Information

Author(s): Sam Schulman, Rajae Elbazi, Michelle Zondag, Martin O'Donnell

Primary Institution: McMaster University

Hypothesis

What clinical characteristics influence the normalization of prothrombin time after stopping warfarin before surgery?

Conclusion

Baseline INR is associated with the rate of normalization of prothrombin time after stopping warfarin, but it is not a reliable predictor in clinical practice.

Supporting Evidence

  • 7% of patients did not normalize their prothrombin time after stopping warfarin for 5 days.
  • Baseline INR was the only significant predictor of slow normalization of prothrombin time.
  • Patients with a baseline INR of 3.0 or higher had a low positive predictive value for slow normalization.

Takeaway

When patients stop taking warfarin before surgery, their blood's ability to clot can take time to return to normal, and this study found that the initial INR level is important for predicting how long it will take.

Methodology

Retrospective cohort study analyzing clinical data from patients who stopped warfarin before surgery.

Potential Biases

Potential selection bias due to exclusion of patients without INR values on the day of surgery.

Limitations

The study did not analyze genetic factors affecting warfarin metabolism and may have selection bias.

Participant Demographics

Patients included were anticoagulated with warfarin for at least one month, with a mean age of 69.4 years.

Statistical Information

P-Value

0.003

Confidence Interval

0.12–0.62

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1477-9560-6-15

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication